A small molecule PK2 antagonist, PKRA7 inhibited tumor growth via interfering neovascularization of glioma and myeloid cell infiltration of pancreatic cancer xenografts, respectively [188] (Table 3). The gene discussed is PROK2; the disease is neoplasm.